NewcelX Ltd. NCEL

About NewcelX Ltd. (NCEL): stock profile, AI score and financials

NewcelX Ltd. (NCEL) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. NCEL is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $0.0m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (FY 2025), NewcelX Ltd. reports net income of $-8.3M, free cash flow of $-2.8M. Top institutional holders of NCEL by reported 13-F value include JONES FINANCIAL COMPANIES LLLP, HRT FINANCIAL, Caitong International Asset Management , Ltd, based on the most recent SEC filings. NCEL trades on the Nasdaq exchange and files with the SEC under CIK 1783036. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NCEL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NewcelX Ltd. directly from SEC EDGAR.

SEC EDGAR: CIK 1783036 →